Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Patients Taking VIMOVO(TM) Showed Decrease in incidence of NSAID Associated Ulcers
-
AstraZeneca Submits Marketing Authorisation Application to European Union for VIMOVO™
-
US Food and Drug Administration Approves CRESTOR for Use in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
-
Study Finds That ONGLYZA (saxagliptin) When Added to Metformin was Non-Inferior to Januvia (sitagliptin) When Added to Metformin in Reducing Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
-
ONGLYZA (saxagliptin) Receives Marketing Authorisation in Europe for the Treatment of Type 2 Diabetes
-
Seroquel XR and Seroquel Approved in Europe for Prevention of Recurrence of Bipolar Disorder
-
Brilinta Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
-
US Court of Appeals Affirms Summary Judgment Decision in Seroquel Patent Litigation
-
AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes to Address Opioid-Induced Constipation
-
AstraZeneca Announces FDA Acceptance of New Drug Application for VIMOVO
Latest articles and press releases
All of our latest press releases and articles are available to explore
